Merck

  • EU to fine Ranbaxy, others for blocking generic drugs 04-06-2013 10:14 AM

    Brussels: A European regulator will fine Denmark's Lundbeck, India's Ranbaxy and seven other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said, its first sanction against "pay-for-delay" deals. Following an inquiry launched in 2009, the European Union's anti-trust regulator will...
  • Patent row: Delhi HC to hear diabetes drug case 23-05-2013 10:15 AM

    New Delhi: The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. Indian pharma company Glenmark recently came out with generic versions of Merck's type-2...
  • MSD India to invest $ 10 mn to reduce maternal mortality 14-05-2013 03:50 PM

    New Delhi: Drug firm MSD India on Tuesday said it will invest USD 10 million over next three years in the country as part of its global initiative to help reduce maternal mortality. As part of the initiative - 'MSD for Mothers', the drug firm would partner three non-governmental organisations...
  • Patent row: HC refuses interim relief to Merck 05-04-2013 05:54 PM

    New Delhi: The Delhi High Court on Friday refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark Pharmaceuticals manufacturing and marketing anti-diabetes drugs Zita and Zita-Met. Justice Rajiv Sahai Endlaw dismissed the interim...
  • Gardasil wins approval for anal cancer 23-12-2010 01:05 PM

    New York: - Merck & Co's Gardasil vaccine won US approval on Wednesday for preventing anal cancer, providing a new weapon against a rare but rising form of the disease. Both the drugmaker and the US Food and Drug Administration announced the approval, which applies to people ages 9 to...